Strides Pharma Science Limited

NSE: STAR · Healthcare

₹986.60
-7.00 (-0.70%)

Last close · 30 Aug 2026, 2:51 am IST

Open
₹999.00
Day high
₹1,001.90
Day low
₹976.00
Volume
2.09 L
Prev close
₹993.60

Price chart

Range
EMA
Also show

Fundamentals

Drug Manufacturers - Specialty & Generic

Valuation

Market Cap
9,402 Cr
Price
1,020.00
P/E (TTM)
16.89
P/E (Fwd)
10.69
P/B
3.03
EV/EBITDA
13.50
EV/Revenue
2.26
PEG
Div Yield
0.49%
52W High
1,231.00
52W Low
768.65
Beta
0.34

Profitability & income

Revenue (TTM)
4,859 Cr
Net Income (TTM)
556 Cr
EBITDA
815 Cr
Gross Margin
55.92%
Op. Margin
8.56%
Net Margin
11.45%
ROE
20.03%
ROA
6.26%
EPS (TTM)
60.38
EPS (Fwd)
95.40

Financial health

Total Debt
1,758 Cr
Total Cash
204 Cr
Debt/Equity
55.82
Current Ratio
1.25
Quick Ratio
0.60
Book Value
337.09
Free Cash Flow
-4 Cr
Op. Cash Flow
703 Cr

Growth

Revenue Growth
11.20%
Earnings Growth
54.40%
Earnings QoQ
54.40%

Quarterly results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-03-311,323 Cr127 Cr243 Cr186 Cr787 Cr1,758 Cr3,108 Cr
2025-12-311,195 Cr202 Cr339 Cr185 Cr732 Cr
2025-06-301,120 Cr100 Cr218 Cr169 Cr675 Cr
2025-03-311,190 Cr82 Cr206 Cr169 Cr691 Cr1,880 Cr2,552 Cr
2024-12-311,154 Cr88 Cr214 Cr162 Cr674 Cr

Annual results

PeriodRevenueNet IncomeEBITDAOp. IncomeGross ProfitOp. Cash FlowTotal DebtEquity
2026-03-314,628 Cr556 Cr1,021 Cr617 Cr2,461 Cr703 Cr1,758 Cr3,108 Cr
2025-03-314,392 Cr3,593 Cr887 Cr580 Cr2,258 Cr684 Cr1,880 Cr2,552 Cr
2024-03-313,730 Cr-71 Cr344 Cr321 Cr1,846 Cr701 Cr2,517 Cr2,126 Cr
2023-03-313,608 Cr-203 Cr175 Cr143 Cr1,862 Cr44 Cr3,030 Cr2,212 Cr
2022-03-31

Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.

Want charts and signals for STAR?

Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.

Sign in